Literature DB >> 1466799

Cytokines in autoimmunity.

F M Brennan1, M Feldmann.   

Abstract

It is now generally accepted that many cytokines are involved in the pathogenesis of autoimmune disease, either directly by causing tissue destruction or indirectly through the activation of autoreactive and inflammatory cells. Thus, cytokines, such as tumor necrosis factor-alpha, are implicated in the pathogenesis of rheumatoid arthritis based on in vitro studies on synovial tissue from patients with rheumatoid arthritis, which suggest that the effects of tumor necrosis factor-alpha are amplified by its potential to induce other pro-inflammatory cytokines, such as interleukin-1 and granulocyte-macrophage colony-stimulating factor. Transgenic mouse technology has shown that mice expressing the human tumor necrosis factor-alpha gene develop a polyarthritis. Interleukin-2 has also been identified by transgenic technology as a cytokine involved in the pathogenesis of insulin-dependent diabetes mellitus through the activation and stimulation of growth of autoreactive T cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1466799     DOI: 10.1016/0952-7915(92)90057-l

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  14 in total

Review 1.  "Stepping-up" from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate.

Authors:  M C Hochberg; J K Tracy; R H Flores
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

2.  Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis.

Authors:  Helmut Wittkowski; Dirk Foell; Erik af Klint; Leen De Rycke; Filip De Keyser; Michael Frosch; Ann-Kristin Ulfgren; Johannes Roth
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

Review 3.  Anti-CD4 monoclonal antibodies in rheumatoid arthritis.

Authors:  E H Choy; G H Kingsley; G S Panayi
Journal:  Springer Semin Immunopathol       Date:  1998

4.  Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with systemic lupus erythematosus.

Authors:  N Tulek; O Aydintug; K Ozoran; H Tutkak; N Duzgun; M Duman; G Tokgoz
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

5.  Allelic variation of the type 2 tumor necrosis factor receptor gene.

Authors:  E E Powell; L S Wicker; L B Peterson; J A Todd
Journal:  Mamm Genome       Date:  1994-11       Impact factor: 2.957

6.  Lacrimal gland inflammation is responsible for ocular pathology in TGF-beta 1 null mice.

Authors:  N L McCartney-Francis; D E Mizel; M Frazier-Jessen; A B Kulkarni; J B McCarthy; S M Wahl
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

7.  Elevated concentrations of interleukin-1 beta and interleukin-1 receptor antagonist in plasma of women with silicone breast implants.

Authors:  E A Ojo-Amaize; O J Lawless; J B Peter
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

Review 8.  Clinical pharmacology and therapeutic potential of monoclonal antibody treatment in rheumatoid arthritis.

Authors:  E H Choy
Journal:  Drugs Aging       Date:  1998-02       Impact factor: 3.923

9.  CpG oligodeoxynucleotides accelerate reovirus type 2-triggered insulitis in DBA/1 suckling mice.

Authors:  T Hayashi; K Yoshinaka; K Hasegawa; K Maeda; T Onodera
Journal:  Int J Exp Pathol       Date:  2002-10       Impact factor: 1.925

10.  Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment.

Authors:  W B van den Berg; L A Joosten; M Helsen; F A van de Loo
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.